- Home
- IPHA vs HQI Comparison
IPHA vs HQI Comparison
Compare IPHA & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- HQI
- Stock Information
- Founded
- IPHA 1999
- HQI 2002
- Country
- IPHA France
- HQI United States
- Employees
- IPHA N/A
- HQI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- HQI Professional Services
- Sector
- IPHA Health Care
- HQI Consumer Discretionary
- Exchange
- IPHA Nasdaq
- HQI Nasdaq
- Market Cap
- IPHA 160.1M
- HQI 143.3M
- IPO Year
- IPHA 2019
- HQI N/A
- Fundamental
- Price
- IPHA N/A
- HQI $10.06
- Analyst Decision
- IPHA Strong Buy
- HQI Strong Buy
- Analyst Count
- IPHA 1
- HQI 2
- Target Price
- IPHA $11.00
- HQI $16.00
- AVG Volume (30 Days)
- IPHA 11.7K
- HQI 14.9K
- Earning Date
- IPHA 03-27-2025
- HQI 08-07-2025
- Dividend Yield
- IPHA N/A
- HQI 2.31%
- EPS Growth
- IPHA N/A
- HQI N/A
- EPS
- IPHA N/A
- HQI 0.24
- Revenue
- IPHA $20,831,349.00
- HQI $33,651,000.00
- Revenue This Year
- IPHA $209.83
- HQI N/A
- Revenue Next Year
- IPHA $83.15
- HQI $4.99
- P/E Ratio
- IPHA N/A
- HQI $39.84
- Revenue Growth
- IPHA N/A
- HQI N/A
- 52 Week Low
- IPHA $1.29
- HQI $9.04
- 52 Week High
- IPHA $3.51
- HQI $15.75
- Technical
- Relative Strength Index (RSI)
- IPHA 39.24
- HQI 51.78
- Support Level
- IPHA $1.71
- HQI $9.79
- Resistance Level
- IPHA $1.90
- HQI $10.35
- Average True Range (ATR)
- IPHA 0.09
- HQI 0.24
- MACD
- IPHA -0.00
- HQI 0.02
- Stochastic Oscillator
- IPHA 40.74
- HQI 64.06
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.